Private Market View

Medyseva

Indore, India · Founded 2021 · Privately Held (backing)

Last price · $/share
Implied valuation
$1.4M
Total raised
$640K
Last round

Key facts

  • Medyseva’s last known valuation is $1.4M (Sep 2022).
  • It has raised $640K; the latest was Later Stage VC ($450K) in Nov 2025.
  • Notable investors include Unicorn India Ventures, Anikarth Venture, AIC RNTU Bhopal, AIC-Prestige, Aarti Gupta15 tracked in total.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 15 names
  • ·Watchlist + deal alerts for Medyseva
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Medyseva are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Medyseva

Operator of a telemedicine healthcare company intended to provide medicines in rural parts of India. The company offers a range of healthcare services such as virtual consultation, online medicine delivery, ambulance booking, home care service, and lab test booking at affordable prices, enabling rural patients to connect with urban doctors and get access to high-quality healthcare services with ease and comfort.

Sector
Healthcare
HQ
Indore, India
Founded
2021
Employees
16
Ownership
Privately Held (backing)
PA Mark — not yet priced

Medyseva doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Medyseva shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Medyseva in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.